Gene therapy: regulatory issues and international approaches to regulation-Reference-Cited by-同舟云学术

Gene therapy: regulatory issues and international approaches to regulation

Published:1997-06 Issue:3 Volume:8 Page:361-369
ISSN:0958-1669
Container-title:Current Opinion in Biotechnology
language:en
Short-container-title:Current Opinion in Biotechnology

Author:

Cohen-Haguenauer Odile

Publisher

Elsevier BV

Subject

Biomedical Engineering,Bioengineering,Biotechnology

Reference25 articles.

1. (International Conference on Harmonisation 3) guidelines fnalised,1996

2. Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation;Cohen-Haguenauer;Hum Gene Ther,1995

3. Safety and regulation at the leading edge of biomedical biotechnology;Cohen-Haguenauer;Curr Opin Biotechnol,1996

4. Orkin SH, Motulsky AG: Report and recommendations of the panel to assess the NIH investment in research on gene therapy. Published 7 December 1995, NIH Directors Office, National Institutes of Health, Bethesda, MA, US.

5. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector;Naldini;Science,1996

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Drug Approval Process in Japan☆;Reference Module in Biomedical Sciences;2014

2. A Historical View on the Creation of the European Society for Cell and Gene Therapy;Human Gene Therapy;2013-01

3. Ethical and Safety Issues;Plasmid Biopharmaceuticals;2011-07-18

4. Good Manufacturing Practice and Validation;Plasmid Biopharmaceuticals;2011-07-18

5. The Drug Approval Process in Japan;xPharm: The Comprehensive Pharmacology Reference;2007